NCT01166893 Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential
| NCT ID | NCT01166893 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Irvine |
| Condition | Skin Burn Multiple |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2010-03 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2010-03 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
According to the National Burn Repository 2007, the most common type of burn injury is a partial thickness burns. The current standard of care for partial thickness burns is two weeks of topical therapy and wound care. Burns that do not heal within two weeks undergo surgical excision and skin grafting.
Eligibility Criteria
Inclusion Criteria: 1. Male / female all age 2. Subjects is an inpatient or out patient with burn wound Exclusion Criteria: 1. Subjects cannot lied flat and still for the duration of the imaging 2. Subjects pregnant.
Contact & Investigator
Anthony Durkin, PhD
PRINCIPAL INVESTIGATOR
University of California, Irvine
Frequently Asked Questions
Who can join the NCT01166893 clinical trial?
This trial is open to participants of all sexes, aged 1 Minute or older, studying Skin Burn Multiple. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01166893 currently recruiting?
Yes, NCT01166893 is actively recruiting participants. Contact the research team at gordon.kennedy@uci.edu for enrollment information.
Where is the NCT01166893 trial being conducted?
This trial is being conducted at Orange, United States.
Who is sponsoring the NCT01166893 clinical trial?
NCT01166893 is sponsored by University of California, Irvine. The principal investigator is Anthony Durkin, PhD at University of California, Irvine. The trial plans to enroll 200 participants.